Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma

Life Sciences

Volumn 91, Issue 23-24, 2012, Pages 1207-1215

  Huang, Zhen ^a   Dong, Lei ^a   Chen, Jijun ^a   Gao, Fengbo ^a   Zhang, Zhengping ^a   Chen, Jiangning ^a   Zhang, Junfeng ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Low molecular weight chitosan; Short hairpin RNA; Vascular endothelial growth factor

Indexed keywords

CHITOSAN; LOW MOLECULAR WEIGHT CHITOSAN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

ANALYSIS OF VARIANCE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHITOSAN; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE TRANSFER TECHNIQUES; LIVER NEOPLASMS; MICE; MICE, INBRED ICR; MICROSCOPY, FLUORESCENCE; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; MUS;

EID: 84869490394     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.09.015     Document Type: Article

References (39)

1. F.Q. An, M. Matsuda, H. Fujii, and Y. Matsumoto Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma J Cancer Res Clin Oncol 126 3 2000 153 160
2. A. Bozkir, and O.M. Saka Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics Drug Deliv 11 2 2004 107 112
3. A.R. Cardones, and L.L. Banez VEGF inhibitors in cancer therapy Curr Pharm Des 12 3 2006 387 394
4. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 6801 2000 249 257
5. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 7347 2011 298 307
6. T.V. Chirila, P.E. Rakoczy, K.L. Garrett, X. Lou, and I.J. Constable The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides Biomaterials 23 2 2002 321 342
7. L. Dong, S. Gao, H. Diao, J. Chen, and J. Zhang Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo J Biomed Mater Res A 84 3 2008 777 784
8. P. Erbacher, S. Zou, T. Bettinger, A.M. Steffan, and J.S. Remy Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability Pharm Res 15 9 1998 1332 1339
9. N. Ferrara VEGF and the quest for tumour angiogenesis factors Nat Rev Cancer 2 10 2002 795 803
10. N. Ferrara VEGF as a therapeutic target in cancer Oncology 69 Suppl. 3 2005 11 16
11. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 6 2003 669 676
12. J. Folkman Clinical applications of research on angiogenesis N Engl J Med 333 26 1995 1757 1763
13. D.J. Gary, N. Puri, and Y.Y. Won Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery J Control Release 121 1-2 2007 64 73
14. G.J. Hannon RNA interference Nature 418 6894 2002 244 251
15. K.A. Howard, U.L. Rahbek, X. Liu, C.K. Damgaard, S.Z. Glud, and M.O. Andersen RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system Mol Ther 14 4 2006 476 484
16. Z. Huang, Z. Zhang, Y. Jiang, D. Zhang, J. Chen, and L. Dong Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy J Control Release 158 2 2012 286 292
17. T. Kamba, and D.M. McDonald Mechanisms of adverse effects of anti-VEGF therapy for cancer Br J Cancer 96 12 2007 1788 1795
18. H. Katas, and H.O. Alpar Development and characterisation of chitosan nanoparticles for siRNA delivery J Control Release 115 2 2006 216 225
19. D.H. Kim, and J.J. Rossi Strategies for silencing human disease using RNA interference Nat Rev Genet 8 3 2007 173 184
20. S.H. Kim, J.H. Jeong, S.H. Lee, S.W. Kim, and T.G. Park Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer J Control Release 129 2 2008 107 116
21. R. Longo, R. Sarmiento, M. Fanelli, B. Capaccetti, D. Gattuso, and G. Gasparini Anti-angiogenic therapy: rationale, challenges and clinical studies Angiogenesis 5 4 2002 237 256
22. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 1-2 2000 271 284
23. M. Mise, S. Arii, H. Higashituji, M. Furutani, M. Niwano, and T. Harada Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor Hepatology 23 3 1996 455 464
24. K. Nagpal, S.K. Singh, and D.N. Mishra Chitosan nanoparticles: a promising system in novel drug delivery Chem Pharm Bull(Tokyo) 58 11 2010 1423 1430
25. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat Rev Drug Discov 9 8 2010 615 627
26. S. Prabha, W.Z. Zhou, J. Panyam, and V. Labhasetwar Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles Int J Pharm 244 1-2 2002 105 115
27. M.N. Ravi Kumar, U. Bakowsky, and C.M. Lehr Preparation and characterization of cationic PLGA nanospheres as DNA carriers Biomaterials 25 10 2004 1771 1777
28. T. Sato, T. Ishii, and Y. Okahata In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency Biomaterials 22 15 2001 2075 2080
29. C. Scholz, and E. Wagner Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers J Control Release 161 2 2012 554 565
30. D. Semela, and J.F. Dufour Angiogenesis and hepatocellular carcinoma J Hepatol 41 5 2004 864 880
31. M.S. Shim, and Y.J. Kwon Efficient and targeted delivery of siRNA in vivo FEBS J 277 23 2010 4814 4827
32. S. Sundaram, L.K. Lee, and C.M. Roth Interplay of polyethyleneimine molecular weight and oligonucleotide backbone chemistry in the dynamics of antisense activity Nucleic Acids Res 35 13 2007 4396 4408
33. K. Suzuki, N. Hayashi, Y. Miyamoto, M. Yamamoto, K. Ohkawa, and Y. Ito Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma Cancer Res 56 13 1996 3004 3009
34. Y. Takei, K. Kadomatsu, Y. Yuzawa, S. Matsuo, and T. Muramatsu A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics Cancer Res 64 10 2004 3365 3370
35. F. Takeshita, and T. Ochiya Therapeutic potential of RNA interference against cancer Cancer Sci 97 8 2006 689 696
36. J.J. Wang, Z.W. Zeng, R.Z. Xiao, T. Xie, G.L. Zhou, and X.R. Zhan Recent advances of chitosan nanoparticles as drug carriers Int J Nanomedicine 6 2011 765 774
37. K.A. Whitehead, R. Langer, and D.G. Anderson Knocking down barriers: advances in siRNA delivery Nat Rev Drug Discov 8 2 2009 129 138
38. H. Yoshiji, S. Kuriyama, J. Yoshii, Y. Ikenaka, R. Noguchi, and D.J. Hicklin Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice Hepatology 39 6 2004 1517 1524
39. L. Zuo, Z. Huang, L. Dong, L. Xu, Y. Zhu, and K. Zeng Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis Gut 59 4 2010 470 479